InvestorsHub Logo
Followers 22
Posts 3636
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Wednesday, 03/13/2024 7:31:15 PM

Wednesday, March 13, 2024 7:31:15 PM

Post# of 167
3 Reasons Why Collegium Pharmaceutical (COLL) Is a Great Growth Stock
Zacks Equity Research
Wed, March 13, 2024

EXCERPTS:
Earnings growth is arguably the most important factor, as stocks exhibiting exceptionally surging profit levels tend to attract the attention of most investors

The company's EPS is expected to grow 15% this year, crushing the industry average, which calls for EPS growth of 14.7%.

Right now, year-over-year cash flow growth for Collegium Pharmaceutical is 27.9%, which is higher than many of its peers. In fact, the rate compares to the industry average of 2.4%.

There have been upward revisions in current-year earnings estimates for Collegium Pharmaceutical. The Zacks Consensus Estimate for the current year has surged 5.2% over the past month.

Bottom Line

While the overall earnings estimate revisions have made Collegium Pharmaceutical a Zacks Rank #1 stock, it has earned itself a Growth Score of A ....

READ MORE:
https://finance.yahoo.com/news/3-reasons-why-collegium-pharmaceutical-164505922.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent COLL News